GO:0001546 preantral ovarian follicle growth: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001546 describes the increase in size of ovarian follicles that are surrounded by two or more layers of granulosa cells, up to the onset of antrum formation.
• This process is controlled by intraovarian paracrine and endocrine signals, including TGF-beta superfamily members, C-type natriuretic peptide, and AMH [1,2,3,5,8].
• Preantral follicle growth is a critical window for follicle recruitment and survival, and its disruption contributes to infertility, endometriosis-related ovarian damage, and premature ovarian insufficiency [4,5,6].
• Key regulatory genes include AMH, INHBA, INHBB, BMP15, GDF9, FSHR, and KITLG, which coordinate granulosa cell proliferation and oocyte-granulosa communication [1,3,5,8].
• In vitro culture systems that support the preantral to early antral transition are essential for fertility preservation and for testing gene function.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate regulators in preantral follicle growth [1,3,6].
Description
Preantral ovarian follicle growth (GO:0001546) is the biological process by which follicles containing two or more layers of granulosa cells enlarge before antrum formation. This stage is a decisive checkpoint in folliculogenesis because it determines the pool of follicles that can subsequently acquire an antral cavity and become ovulatory [1,3]. Understanding the molecular control of preantral growth is therefore central to reproductive biology and to clinical problems such as infertility, endometriosis-associated ovarian damage, and premature ovarian insufficiency [4,5,6]. The process is regulated by an intricate network of intraovarian factors, including TGF-beta superfamily ligands, C-type natriuretic peptide, and anti-Mullerian hormone, which act on granulosa cells and the oocyte to drive coordinated growth [1,2,3,5,8]. Because preantral follicles are small and difficult to manipulate in vivo, researchers rely on in vitro culture systems and genetically modified models to dissect gene function. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0001546, its key genes, regulatory mechanisms, disease links, and experimental methods.
preantral ovarian follicle growth At A Glance
| GO ID | GO:0001546 |
|---|---|
| GO term | preantral ovarian follicle growth |
| Ontology | biological_process |
| Synonym | none |
| Major function | Increase in size of follicles with two or more granulosa cell layers before antrum formation |
| Upstream process | Primordial follicle activation and primary follicle formation |
| Downstream process | Antral follicle formation and ovulation |
| Key cell types | Granulosa cells, oocyte, theca cells |
| Representative regulators | AMH, C-type natriuretic peptide, TGF-beta superfamily ligands, FSHR, KITLG |
What Is GO:0001546?
GO:0001546, preantral ovarian follicle growth, is defined by QuickGO as the increase in size of follicles surrounded by two or more layers of granulosa cells up to the onset of antrum formation. In other words, it covers the developmental interval during which a multilayered secondary follicle expands without yet forming a fluid-filled antral cavity. This process is distinct from earlier follicle activation and from later antral follicle growth, and it depends on bidirectional signaling between the oocyte and surrounding granulosa cells [1,3].
Why Is preantral ovarian follicle growth Important in Cell Biology?
Preantral ovarian follicle growth is important because it sets the size and quality of the follicle pool available for ovulation and thus directly influences female fertility [1,3]. Disruption of this process is linked to ovarian endometrioma-related damage, altered ovary size, and infertility [4,5]. Because preantral follicles are the most abundant growing follicles in the ovary, understanding their growth control is essential for developing fertility preservation strategies and for interpreting reproductive toxicity.
• Determines the number of follicles that can progress to the antral stage and ovulate.
• Integrates endocrine and paracrine signals such as AMH, C-type natriuretic peptide, and TGF-beta family members [2,5,8].
• Provides a target for fertility preservation and in vitro follicle culture.
• Is impaired in endometriosis-related infertility and ovarian endometrioma.
• Contributes to regulation of ovary size through clustered follicle growth.
• Involves oocyte-granulosa cell communication essential for oocyte competence.
• Serves as a model for studying TGF-beta superfamily signaling in reproductive tissue.
• Is relevant to premature ovarian insufficiency and diminished ovarian reserve [1,6].
• Can be modeled with CRISPR knockout and knock-in approaches to test causal genes [1,3].
• Supports development of culture systems for preantral to early antral transition.
What Happens During preantral ovarian follicle growth?
Initiation from multilayered secondary follicles
In simple terms: This is the starting point where a follicle already has two or more layers of granulosa cells and begins to enlarge.
Preantral ovarian follicle growth begins when follicles have acquired two or more layers of granulosa cells and enter a phase of coordinated expansion before antrum formation. This stage follows primordial follicle activation and primary follicle formation, and it is characterized by granulosa cell proliferation and oocyte growth [1,3]. Intraovarian factors such as TGF-beta superfamily ligands and C-type natriuretic peptide support this transition [2,8].
Granulosa cell proliferation and differentiation
In simple terms: The granulosa cells multiply and specialize, which increases follicle size.
During preantral growth, granulosa cells proliferate and begin to differentiate, forming multiple layers around the oocyte [1,3]. This proliferation is stimulated by paracrine signals including C-type natriuretic peptide, which enhances mouse preantral follicle growth. Anti-Mullerian hormone also modulates this phase by counteracting clustered follicle growth and regulating ovary size.
Oocyte-granulosa cell communication
In simple terms: The egg and its surrounding cells talk to each other to coordinate growth.
Bidirectional communication between the oocyte and granulosa cells is essential for preantral follicle growth. Oocyte-derived factors such as GDF9 and BMP15 regulate granulosa cell function, while granulosa cell-derived factors support oocyte development [1,3]. Disruption of this communication impairs follicle growth and can lead to infertility.
Regulation by TGF-beta superfamily signaling
In simple terms: A family of growth factors controls how fast and how far the follicle grows.
Transforming growth factor-beta superfamily members, including activins, inhibins, and bone morphogenetic proteins, play central roles in ovarian follicle development. Mullerian inhibitory substance induces growth of rat preantral ovarian follicles, demonstrating direct regulation of this stage. These signals act through SMAD-dependent pathways in granulosa cells to control proliferation and differentiation.
Transition toward antrum formation
In simple terms: The follicle prepares to form a fluid-filled cavity, marking the end of preantral growth.
Preantral growth culminates in the onset of antrum formation, when the follicle acquires a fluid-filled cavity. The mechanisms controlling the preantral to early antral transition are critical for efficient in vitro culture systems. AMH regulates ovary size by counteracting the positive influence of clustered ovarian follicle growth, influencing the timing of this transition.
Key Genes Involved in GO:0001546 preantral ovarian follicle growth
The following genes and proteins are established regulators of preantral ovarian follicle growth based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AMH | Modulates follicle recruitment and ovary size | Knockout models show altered follicle growth and ovary size |
| INHBA | Activin subunit regulating granulosa cell proliferation | Involved in TGF-beta superfamily control of follicle growth |
| INHBB | Inhibin/activin subunit | Regulates paracrine signaling in preantral follicles |
| BMP15 | Oocyte-derived growth factor | Essential for granulosa cell function and follicle growth [1,3] |
| GDF9 | Oocyte-derived growth factor | Critical for preantral follicle development [1,3] |
| FSHR | Follicle-stimulating hormone receptor | Mediates endocrine control of follicle growth |
| KITLG | Kit ligand supporting granulosa cell survival | Important for preantral follicle growth [1,3] |
| NPPC | C-type natriuretic peptide precursor | Enhances mouse preantral follicle growth |
| NPR2 | C-type natriuretic peptide receptor | Mediates CNP effects on follicle growth |
| MIS/AMH | Mullerian inhibitory substance | Induces growth of rat preantral ovarian follicles |
| TGFB1 | Transforming growth factor beta 1 | Regulates ovarian follicle development |
| SMAD2 | TGF-beta signaling effector | Transduces growth signals in granulosa cells |
| SMAD3 | TGF-beta signaling effector | Regulates granulosa cell proliferation |
| FOXL2 | Granulosa cell transcription factor | Maintains granulosa cell identity during growth |
| NR5A1 | Nuclear receptor regulating steroidogenesis | Supports follicle growth and function |
| CTNNB1 | Wnt signaling effector | Modulates granulosa cell proliferation |
| PTEN | PI3K pathway regulator | Controls follicle activation and growth |
How Is preantral ovarian follicle growth Regulated?
Preantral ovarian follicle growth is regulated by a complex interplay of endocrine and paracrine signals. Intraovarian control of early folliculogenesis involves TGF-beta superfamily ligands, C-type natriuretic peptide, and AMH, which act on granulosa cells to modulate proliferation and differentiation [1,2,5,8]. C-type natriuretic peptide enhances mouse preantral follicle growth through its receptor NPR2. AMH regulates ovary size by counteracting the positive influence of clustered ovarian follicle growth. Mullerian inhibitory substance induces growth of rat preantral ovarian follicles, demonstrating direct regulation. The PI3K/PTEN pathway and FOXL2 also contribute to the control of follicle activation and growth. These regulatory mechanisms ensure that follicle growth is coordinated with oocyte development and the reproductive cycle.
preantral ovarian follicle growth and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AMH | Altered ovary size and follicle recruitment | Knockout mouse and granulosa cell overexpression |
| GDF9 | Premature ovarian insufficiency | Knock-in of patient variants in mouse models [1,3] |
| BMP15 | Ovarian dysgenesis and infertility | Point mutation knock-in in mice [1,3] |
| FSHR | Ovarian failure and infertility | Knockout and knock-in models |
| NPPC | Impaired preantral follicle growth | Overexpression and knockout in mice |
Endometriosis-related infertility
Ovarian endometriomas negatively impact preantral follicle development, contributing to endometriosis-related infertility. The presence of endometriomas is associated with reduced follicle growth and impaired ovarian reserve. Understanding how endometriomas disrupt GO:0001546 may inform fertility preservation strategies.
Premature ovarian insufficiency and diminished ovarian reserve
Disruption of preantral follicle growth can lead to premature ovarian insufficiency and diminished ovarian reserve [1,6]. Genes such as AMH, GDF9, and BMP15 are implicated in follicle growth arrest and ovarian failure [1,3]. In vitro culture systems for preantral follicles are being developed to study and potentially treat these conditions.
Polycystic ovary syndrome and altered follicle recruitment
Altered regulation of preantral follicle growth may contribute to abnormal follicle recruitment in polycystic ovary syndrome [1,5]. AMH, which regulates ovary size and follicle growth, is often elevated in PCOS. Targeting preantral growth regulators could provide therapeutic avenues.
From preantral ovarian follicle growth-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate preantral follicle growth? | Knockout mouse or granulosa cell-specific KO [1,3] |
| Does a patient variant alter follicle growth? | Point mutation knock-in in mice [1,3] |
| Does overexpression of gene X enhance follicle growth? | Transgenic overexpression or viral delivery |
| How does gene X affect oocyte-granulosa communication? | Tagged knock-in and imaging |
| What is the role of gene X in endometriosis-related damage? | Endometrioma mouse models with KO |
| Can gene X improve in vitro follicle culture? | CRISPR-edited granulosa cells in culture |
How to Study the preantral ovarian follicle growth Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro follicle culture | Follicle growth and survival | Testing gene function and fertility preservation |
| Histology | Follicle stage and morphology | Assessing preantral growth in vivo |
| Immunohistochemistry | Protein localization and proliferation | Identifying granulosa cell changes |
| RNA-seq | Transcriptional profiles | Discovering regulators of follicle growth [1,8] |
| qPCR | Expression of candidate genes | Validating key regulators [2,5] |
| Knockout mouse | Causal role of a gene | Testing gene function in vivo [1,3] |
| Knock-in mouse | Effect of patient variants | Modeling human infertility mutations [1,3] |
| Overexpression | Gain-of-function effects | Enhancing follicle growth in culture |
In vitro follicle culture
In vitro culture systems that support the preantral to early antral transition are essential for studying follicle growth and for fertility preservation. These systems allow controlled manipulation of gene expression and real-time monitoring of follicle development.
Histology and immunohistochemistry
Histological analysis and immunohistochemistry are used to assess follicle stage, granulosa cell proliferation, and oocyte growth during preantral development [1,3]. These methods provide spatial information about follicle architecture.
Gene expression analysis
RNA-seq and quantitative PCR are used to measure expression of key regulators such as AMH, GDF9, BMP15, and NPPC during preantral follicle growth [1,2,5]. These approaches identify transcriptional changes associated with growth.
Genetic mouse models
Knockout, knock-in, and transgenic mouse models are used to test the causal role of specific genes in preantral follicle growth [1,3,7]. These models allow in vivo assessment of follicle number, size, and fertility.
How CRISPR Can Be Used to Study GO:0001546 preantral ovarian follicle growth
Knockout
CRISPR knockout of candidate genes such as AMH, GDF9, or BMP15 in mice or granulosa cell lines can determine whether they are required for preantral follicle growth [1,3]. Knockout models reveal loss-of-function phenotypes including altered follicle number and size.
Point Mutation
CRISPR point mutation knock-in can introduce patient-specific variants into genes like FSHR or BMP15 to test their impact on preantral follicle growth [1,3]. This approach models human infertility mutations in vivo.
Knock-in
Knock-in of tagged versions of genes such as GDF9 or AMH allows tracking of protein localization and interaction during preantral follicle growth. This helps define signaling dynamics in granulosa cells.
Overexpression
CRISPR-mediated overexpression of growth factors like NPPC or GDF9 can enhance preantral follicle growth in culture or in vivo. Overexpression models are useful for testing therapeutic potential.
How EDITGENE Supports preantral ovarian follicle growth Research
Researchers studying preantral ovarian follicle growth-related genes often need to determine whether a candidate gene is causally involved in follicle development or is merely a biomarker. EDITGENE provides CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional studies of GO:0001546.
Contact EDITGENE today to design your custom CRISPR model for preantral ovarian follicle growth research.
Frequently Asked Questions About preantral ovarian follicle growth
What is GO:0001546?
GO:0001546 is the Gene Ontology term for preantral ovarian follicle growth, defined as the increase in size of follicles surrounded by two or more layers of granulosa cells up to the onset of antrum formation.
What genes are involved in preantral ovarian follicle growth?
Key genes include AMH, GDF9, BMP15, FSHR, INHBA, INHBB, NPPC, and KITLG, which regulate granulosa cell proliferation and oocyte communication [1,2,3,5,8].
How is preantral follicle growth regulated?
It is regulated by intraovarian factors such as TGF-beta superfamily ligands, C-type natriuretic peptide, and AMH, which act on granulosa cells [1,2,5,8].
What is the role of AMH in preantral follicle growth?
AMH regulates ovary size by counteracting the positive influence of clustered ovarian follicle growth.
What is the role of C-type natriuretic peptide in preantral follicle growth?
C-type natriuretic peptide enhances mouse preantral follicle growth through its receptor NPR2.
How does endometriosis affect preantral follicle growth?
Ovarian endometriomas negatively impact preantral follicle development, contributing to endometriosis-related infertility.
What methods are used to study preantral follicle growth?
In vitro follicle culture, histology, RNA-seq, and genetic mouse models are commonly used [1,3,6].
Can CRISPR be used to study preantral follicle growth?
Yes, CRISPR knockout, knock-in, and overexpression models allow causal testing of candidate genes in follicle growth [1,3].
What diseases are linked to preantral follicle growth defects?
Endometriosis-related infertility, premature ovarian insufficiency, and diminished ovarian reserve are linked to disrupted preantral growth [1,4,6].
Why is preantral follicle growth important for fertility?
It determines the pool of follicles that can progress to ovulation, directly affecting female fertility [1,3].
Conclusion
Preantral ovarian follicle growth (GO:0001546) is a critical biological process that governs the expansion of multilayered follicles before antrum formation. It is controlled by a network of intraovarian signals including TGF-beta superfamily members, C-type natriuretic peptide, and AMH, and its disruption is linked to infertility and ovarian disease [1,2,4,5,8]. Continued research using CRISPR models and in vitro culture systems will advance our understanding and support clinical applications [3,6].
References
- 1. Hsueh AJ et al.. 2015. Intraovarian control of early folliculogenesis.. Endocr Rev 36(1):1-24 PMID: 25202833
- 2. Xi G et al.. 2019. C-type natriuretic peptide enhances mouse preantral follicle growth.. Reproduction 157(5):445-455 PMID: 30817314
- 3. McGee EA et al.. 2015. Regulators of ovarian preantral follicle development.. Semin Reprod Med 33(3):179-84 PMID: 26036899
- 4. Orisaka M et al.. 2026. Negative impacts of ovarian endometrioma on preantral follicle development: implications for endometriosis-related infertility.. Front Endocrinol (Lausanne) 17:1679042 PMID: 42199791
- 5. Lim C et al.. 2026. AMH regulates ovary size by counteracting the positive influence of clustered ovarian follicle growth.. Hum Reprod 41(5):795-808 PMID: 41742785
- 6. Nascimento DR et al.. 2023. The mechanisms that control the preantral to early antral follicle transition and the strategies to have efficient culture systems to promote their growth in vitro.. Zygote 31(4):305-315 PMID: 37221099
- 7. McGee EA et al.. 2001. Müllerian inhibitory substance induces growth of rat preantral ovarian follicles.. Biol Reprod 64(1):293-8 PMID: 11133686
- 8. Rosairo D et al.. 2008. Transforming growth factor-beta: its role in ovarian follicle development.. Reproduction 136(6):799-809 PMID: 18780765
